Brief: Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform To Advance Patient Care
20/12/2023 13:07
Dec 20 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ESTABLISHES COMPREHENSIVE PAN-CANCER
RESEARCH
PLATFORM TO ADVANCE PATIENT CARE
Source text for Eikon: ID:nGNXbyWBjn
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple